Aldeyra Therapeutics Provides Regulatory Update on ADX-2191

1 year ago

by David Miller

948 Views

Written by David Miller

LEXINGTON, Mass.–(BUSINESS WIRE)–Jun. 21, 2023– (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced receipt of a Complete…Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts

[mwai_chat window="true" fullscreen="true"]

You may also like

About the author

David Miller

Don`t Leave Yet!